Rationale for standardized staging laparoscopy before neoadjuvant therapy in locally advanced gastric cancer.

Authors

Katarzyna Gęca, Magdalena Skórzewska, Johanna W van Sandick, Wojciech P Polkowski

Published in

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. Volume 52. Issue 12. Pages 112155. Sep 17, 2026. Epub Sep 17, 2026.

Abstract

Peritoneal metastasis (PM) is a dominant mode of failure in gastric and gastroesophageal junction adenocarcinoma and is associated with poor survival, particularly when radiographically occult at diagnosis. Cross-sectional imaging has limited sensitivity for low-volume peritoneal disease, and a clinically relevant proportion of patients with apparently non-metastatic, locally advanced tumours on computed tomography harbor macroscopic PM or positive peritoneal cytology, both classified as stage IV disease. International guidelines therefore recommend staging laparoscopy (SL) with peritoneal washings in patients with potentially resectable, locally advanced tumours prior to neoadjuvant systemic therapy or curative-intent gastrectomy. Nevertheless, real-world implementation remains inconsistent, while contemporary series report upstaging rates of approximately 20-40% among guideline-eligible patients. This narrative review summarizes current evidence regarding the diagnostic yield and limitations of SL, clinicopathologic predictors of occult peritoneal dissemination, and the downstream consequences of omitting peritoneal staging. Failure to perform SL may result in inaccurate stage assignment, delayed initiation of stage-appropriate systemic therapy, and exposure to non-beneficial gastrectomy in patients with occult peritoneal stage IV disease. The implications for biomarker-driven treatment strategies, regional approaches targeting peritoneal disease, and clinical trial eligibility are also discussed. Finally, a pragmatic framework for integrating SL into routine multidisciplinary care pathways is proposed.

PMID:
42762780
Bibliographic data and abstract were imported from PubMed on 20 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.